Ronald Ackermann

Dr. Ronald Ackermann

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in American Journal of Public Health
Verified
Journal Article
Closed access
RARonald Ackermann
Ronald Ackermann
DLDavid T. Liss
David T. Liss
EFEmily A. Finch
Emily A. Finch
KSKaren K. Schmidt
Karen K. Schmidt
LHLaura M. Hays
Laura M. Hays
CSChandan Saha
Chandan Saha
Objectives. We evaluated the weight loss effectiveness of a YMCA model for the Diabetes Prevention Program (DPP) lifestyle intervention. Methods. Between July 2008 and November 2010, we individually randomized 509 overweight or obese, low-income, nondiabetic adults with elevated blood glucose in Indianapolis, Indiana, to receive standard care plus brief lifestyle counseling or be offered a group-based YMCA adaptation of the DPP (YDPP). Primary outcome was mean weight loss difference at 12 months. In our intention-to-treat analyses, we used longitudinal linear or logistic regression, multiply imputing missing observations. We used instrumental variables regression to estimate weight loss effectiveness among participants completing 9 or more intervention lessons. Results. In the YDPP arm, 161 (62.6%) participants attended ≥ 1 lesson and 103 (40.0%) completed 9 or more lessons. In intention-to-treat analysis, mean 12-month weight loss was 2.3 kilograms (95% confidence interval [CI] = 1.1, 3.4 kg) more for the YDPP arm than for standard care participants. In instrumental variable analyses, persons attending 9 or more lessons had a 5.3-kilogram (95% CI = 2.8, 7.9 kg) greater weight loss than did those with standard care alone. Conclusions. The YMCA model for DPP delivery achieves meaningful weight loss at 12 months among low-income adults.

20 February 2020 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
RARonald Ackermann
Ronald Ackermann
MOMatthew J. O’bRien
Matthew J. O’bRien


1 June 2015 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
RARonald Ackermann
Ronald Ackermann
ODO. Kenrik Duru
O. Kenrik Duru
JAJeanine B. Albu
Jeanine B. Albu
JSJulie A. Schmittdiel
Julie A. Schmittdiel
SSStephen B. Soumerai
Stephen B. Soumerai
EGEdward W. Gregg
Edward W. Gregg

17 April 2014 in Obesity
Verified
Journal Article
Open access
PDF file
RARonald Ackermann
Ronald Ackermann
LSLewis G. Sandy
Lewis G. Sandy
TBTom Beauregard
Tom Beauregard
MCMark Coblitz
Mark Coblitz
KNKristi L. Norton
Kristi L. Norton
DVDeneen Vojta
Deneen Vojta
Objective: To evaluate the use and effectiveness of two “in‐home” strategies for delivering diabetes prevention programming using cable television.Methods: An individually randomized, two‐arm intervention trial including adults with diabetes risk factors living in two US cities. Interventions involved a 16‐session lifestyle intervention delivered via “video‐on‐demand” cable television, offered alone versus in combination with web‐based lifestyle support tools. Repeated measures longitudinal linear regression with imputation of missing observations was used to compare changes in body weight.Results: A total of 306 individuals were randomized and offered the interventions. After 5 months, 265 (87%) participants viewed at least 1, and 110 (36%) viewed ≥9 of the video episodes. A total of 262 (86%) participants completed a 5‐month weight measurement. In intention‐to‐treat analysis with imputation of missing observations, mean weight loss at 5 months for both treatment groups combined was 3.3% (95% CI 0.7‐5.0%), regardless of intervention participation (with no differences between randomized groups (P = 0.19)), and was 4.9% (95% CI 2.1‐6.5%) for participants who viewed ≥9 episodes.Conclusions: In‐home delivery of evidence‐based diabetes prevention programming in a reality television format, offered with or without online behavioral support tools, can achieve modest weight losses consistent with past implementation studies of face‐to‐face programs using similar content.

21 September 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
LPLaura M. Perry
Laura M. Perry
VMVictoria Morken
Victoria Morken
JPJohn Devin Peipert
John Devin Peipert
BYBetina Yanez
Betina Yanez
SGSofia F. Garcia
Sofia F. Garcia
DCDavid Cella
David Cella
Background: Patient-reported outcomes—symptoms, treatment side effects, and health-related quality of life—are important to consider in chronic illness care. The increasing availability of health IT to collect patient-reported outcomes and integrate results within the electronic health record provides an unprecedented opportunity to support patients’ symptom monitoring, shared decision-making, and effective use of the health care system. Objective: The objectives of this study are to co-design a dashboard that displays patient-reported outcomes along with other clinical data (eg, laboratory tests, medications, and appointments) within an electronic health record and conduct a longitudinal demonstration trial to evaluate whether the dashboard is associated with improved shared decision-making and disease management outcomes. Methods: Co-design teams comprising study investigators, patients with advanced cancer or chronic kidney disease, their care partners, and their clinicians will collaborate to develop the dashboard. Investigators will work with clinic staff to implement the co-designed dashboard for clinical testing during a demonstration trial. The primary outcome of the demonstration trial is whether the quality of shared decision-making increases from baseline to the 3-month follow-up. Secondary outcomes include longitudinal changes in satisfaction with care, self-efficacy in managing treatments and symptoms, health-related quality of life, and use of costly and potentially avoidable health care services. Implementation outcomes (ie, fidelity, appropriateness, acceptability, feasibility, reach, adoption, and sustainability) during the co-design process and demonstration trial will also be collected and summarized. Results: The dashboard co-design process was completed in May 2020, and data collection for the demonstration trial is anticipated to be completed by the end of July 2022. The results will be disseminated in at least one manuscript per study objective. Conclusions: This protocol combines stakeholder engagement, health care coproduction frameworks, and health IT to develop a clinically feasible model of person-centered care delivery. The results will inform our current understanding of how best to integrate patient-reported outcome measures into clinical workflows to improve outcomes and reduce the burden of chronic disease on patients and health care systems. International Registered Report Identifier (IRRID): DERR1-10.2196/38461